Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/107441
Title: Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors
Authors: Brandão, Pedro 
López, Óscar
Leitzbach, Luisa
Stark, Holger
Fernández-Bolaños, José G.
Burke, Anthony J.
Pineiro, Marta 
Issue Date: 11-Nov-2021
Publisher: ACS American Chemical Society
Project: P. Brandão acknowledges FCT for the PhD grant PD/BD/ 128490/2017-CATSUS FCT-PhD Program. Coimbra Chemistry Centre (CQC) is supported by the Portuguese Agency for Scientific Research, “Fundação para a Ciência e a Tecnologia” (FCT) through project UIDB/00313/2020 and UIDP/00313/ 2020, cofunded by COMPETE2020-UE. We also acknowledge the UC-NMR facility for obtaining the NMR data (www. nmrccc.uc.pt). This work was also financed by the FEDER Funds through the Operational Competitiveness Factors ProgramCOMPETEand by National Funds through FCTFoundation for Science and Technologywithin the scope of the project UIDB/50006/2020. Ó. López would also like to thank the Dirección General de Investigación of Spain (CTQ2016-78703-P), Junta de Andalucía (FQM134), and FEDER (501100008530) for financial support. Partial support from the EU COST Actions CA15135 (to HS and AJB), CA18133 (to HS), and CA18240 (to HS) is also acknowledged. 
Serial title, monograph or event: ACS Medicinal Chemistry Letters
Volume: 12
Issue: 11
Abstract: Molecular hybridization is a valuable approach in drug discovery. Combining it with multicomponent reactions is highly desirable, since structurally diverse libraries can be attained efficiently in an eco-friendly manner. In this work, isatin is used as the key building block for the Ugi 4-center 3-component reaction synthesis of oxindole-lactam hybrids, under catalyst-free conditions. The resulting oxindole-β-lactam and oxindole-γ-lactam hybrids were evaluated for their potential to inhibit relevant central nervous system targets, namely cholinesterases and monoamine oxidases. Druglikeness evaluation was also performed, and compounds 4eca and 5dab exhibited great potential as selective butyrylcholinesterase inhibitors, at the low micromolar range, with an interesting predictive pharmacokinetic profile. Our findings herein reported suggest oxindole-lactam hybrids as new potential agents for the treatment of Alzheimer's disease.
URI: https://hdl.handle.net/10316/107441
ISSN: 1948-5875
DOI: 10.1021/acsmedchemlett.1c00344
Rights: embargoedAccess
Appears in Collections:I&D CQC - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
Brandao2021ACSMedChemLett.pdf2.89 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

12
checked on Apr 22, 2024

WEB OF SCIENCETM
Citations

13
checked on Apr 2, 2024

Page view(s)

36
checked on Apr 23, 2024

Download(s)

17
checked on Apr 23, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons